Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANKRD42 divergent transcript (ANKRD42-DT)
- Target
- ANKRD42-DT
- Molecular classification
- Other (long non-coding RNA, lncRNA)
01
Overview
ANKRD42 divergent transcript (ANKRD42-DT) is a long non-coding RNA (lncRNA) gene located near and transcribed in the opposite direction (divergent) from the protein-coding ANKRD42 gene. Its classification as a divergent transcript relative to ANKRD42 suggests a possible regulatory role in modulating the expression of the nearby protein-coding gene, but there is no evidence that it encodes a protein or possesses enzymatic, receptor, or transporter activity. The function and clinical relevance of ANKRD42-DT are largely unknown; current genomic databases annotate it as a non-coding gene with no established disease associations, therapeutic targeting, or utility as a biomarker[9][3][1].
- Other names
- ANKRD42-DT
02
Biological functions
Other (Possible regulation of gene expression for the protein-coding ANKRD42 gene)
03
Disease associations
Other (No direct, well-established disease association for the lncRNA itself; ANKRD42 protein may have implications in signaling/inflammation, but ANKRD42-DT-specific roles are not documented)
Beyond the preview
Go deeper on ANKRD42 divergent transcript (ANKRD42-DT).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ANKRD42 divergent transcript (ANKRD42-DT).